These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression analysis of two mutations in carnitine palmitoyltransferase IA deficiency. Ogawa E; Kanazawa M; Yamamoto S; Ohtsuka S; Ogawa A; Ohtake A; Takayanagi M; Kohno Y J Hum Genet; 2002; 47(7):342-7. PubMed ID: 12111367 [TBL] [Abstract][Full Text] [Related]
3. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency. Stanley CA Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304 [TBL] [Abstract][Full Text] [Related]
4. Novel mutations in CPT 1A define molecular heterogeneity of hepatic carnitine palmitoyltransferase I deficiency. Bennett MJ; Boriack RL; Narayan S; Rutledge SL; Raff ML Mol Genet Metab; 2004 May; 82(1):59-63. PubMed ID: 15110323 [TBL] [Abstract][Full Text] [Related]
5. [Molecular analysis of a patient with carnitine palmitoyltransferase II deficiency]. Akanuma J; Wataya K; Matubara Y; Yamamoto T; Kira J; Narisawa K Rinsho Shinkeigaku; 1997 Jun; 37(6):532-5. PubMed ID: 9366186 [TBL] [Abstract][Full Text] [Related]
6. A novel mutation identified in carnitine palmitoyltransferase II deficiency. Yang BZ; Ding JH; Roe D; Dewese T; Day DW; Roe CR Mol Genet Metab; 1998 Feb; 63(2):110-5. PubMed ID: 9562964 [TBL] [Abstract][Full Text] [Related]
7. Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmitoyltransferase II deficiency. Isackson PJ; Bennett MJ; Vladutiu GD Mol Genet Metab; 2006 Dec; 89(4):323-31. PubMed ID: 16996287 [TBL] [Abstract][Full Text] [Related]
8. [Heterogeneity of carnitine palmitoyltransferase deficiencies. Deficiency of CPT I in the hepatic form and CPT II in the muscular form]. Bonnefont JP; Ogier H; Mitchell G; Demaugre F; Pelet A; Saudubray JM; Frezal J Arch Fr Pediatr; 1985; 42 Suppl 1():613-7. PubMed ID: 4083994 [TBL] [Abstract][Full Text] [Related]
10. Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency. Corti S; Bordoni A; Ronchi D; Musumeci O; Aguennouz M; Toscano A; Lamperti C; Bresolin N; Comi GP J Neurol Sci; 2008 Mar; 266(1-2):97-103. PubMed ID: 17936304 [TBL] [Abstract][Full Text] [Related]
11. Autopsy case of the neonatal form of carnitine palmitoyltransferase-II deficiency triggered by a novel disease-causing mutation del1737C. Semba S; Yasujima H; Takano T; Yokozaki H Pathol Int; 2008 Jul; 58(7):436-41. PubMed ID: 18577113 [TBL] [Abstract][Full Text] [Related]
12. Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation. Saudubray JM; Coudé FX; Demaugre F; Johnson C; Gibson KM; Nyhan WL Pediatr Res; 1982 Oct; 16(10):877-81. PubMed ID: 7145511 [TBL] [Abstract][Full Text] [Related]
13. Identification of four novel mutations in patients with carnitine palmitoyltransferase II (CPT II) deficiency. Yang BZ; Ding JH; Dewese T; Roe D; He G; Wilkinson J; Day DW; Demaugre F; Rabier D; Brivet M; Roe C Mol Genet Metab; 1998 Aug; 64(4):229-36. PubMed ID: 9758712 [TBL] [Abstract][Full Text] [Related]
14. Cloning and expression of the liver and muscle isoforms of ovine carnitine palmitoyltransferase 1: residues within the N-terminus of the muscle isoform influence the kinetic properties of the enzyme. Price NT; Jackson VN; van der Leij FR; Cameron JM; Travers MT; Bartelds B; Huijkman NC; Zammit VA Biochem J; 2003 Jun; 372(Pt 3):871-9. PubMed ID: 12662154 [TBL] [Abstract][Full Text] [Related]
20. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique. Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]